Coldstream Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Coldstream Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-231	Closed	-$19.4K	–	2340
2025 Q1	$19.4K	Buy	+231	New	+$21.5K	﹤0.01%	2127

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Coldstream Capital Management's LMAT Position: Q2 2025 in Review

Coldstream Capital Management sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 231 shares — an estimated $19.4K sold.

Coldstream Capital Management first reported a position in LMAT in Q1 2025 and held it in 1 quarter. The position peaked at $19.4K in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

Coldstream Capital Management reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
Coldstream Capital Management sold 231 LeMaitre Vascular shares in Q2 2025, an estimated $19.4K.
Coldstream Capital Management first reported a position in LeMaitre Vascular in Q1 2025 and held it in 1 quarter.
Coldstream Capital Management's LeMaitre Vascular position peaked at $19.4K in Q1 2025.
283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.